456 related articles for article (PubMed ID: 9338580)
1. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers.
Victoria T; Rafi MA; Wenger DA
Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004
[TBL] [Abstract][Full Text] [Related]
4. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
5. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
6. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta).
Baskin GB; Ratterree M; Davison BB; Falkenstein KP; Clarke MR; England JD; Vanier MT; Luzi P; Rafi MA; Wenger DA
Lab Anim Sci; 1998 Oct; 48(5):476-82. PubMed ID: 10090061
[TBL] [Abstract][Full Text] [Related]
7. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; Krabbe disease and galactosylceramidase deficiency].
Kleijer WJ; van Diggelen OP; Halley DJ; van der Ploeg AT; Mancini GM
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):826-8. PubMed ID: 15141649
[TBL] [Abstract][Full Text] [Related]
9. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of late-life globoid cell leukodystrophy.
De Gasperi R; Gama Sosa MA; Sartorato E; Battistini S; Raghavan S; Kolodny EH
Hum Mutat; 1999; 14(3):256-62. PubMed ID: 10477434
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of globoid cell leukodystrophy in Irish setters.
McGraw RA; Carmichael KP
Vet J; 2006 Mar; 171(2):370-2. PubMed ID: 16490723
[TBL] [Abstract][Full Text] [Related]
12. Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease.
Luzi P; Rafi MA; Wenger DA
Ann Neurol; 1996 Jul; 40(1):116-9. PubMed ID: 8687180
[TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
15. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
Shin D; Feltri ML; Wrabetz L
J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
17. Somatic cell genetic analysis of the galactocerebrosidase gene: lack of complementation in human Krabbe disease/twitcher mouse cell hybrids.
Skiba MC; Lyerla TA; Konola JT; Raghavan S
J Neurosci Res; 1990 Dec; 27(4):472-8. PubMed ID: 2079710
[TBL] [Abstract][Full Text] [Related]
18. [Krabbe disease (globoid cell leukodystrophy)].
Sakai N; Inui K; Okada S
Nihon Rinsho; 1995 Dec; 53(12):2947-51. PubMed ID: 8577041
[TBL] [Abstract][Full Text] [Related]
19. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy.
Luddi A; Strazza M; Carbone M; Moretti E; Costantino-Ceccarini E
Exp Cell Res; 2005 Mar; 304(1):59-68. PubMed ID: 15707574
[TBL] [Abstract][Full Text] [Related]
20. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
